End-of-day quote
Other stock markets
|
||
- INR | - |
Apr. 18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
Apr. 17 | Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit | MT |
Sales 2022 | 11.47B 138M | Sales 2023 | 10.52B 126M | Capitalization | 19.91B 239M |
---|---|---|---|---|---|
Net income 2022 | 607M 7.29M | Net income 2023 | -325M -3.9M | EV / Sales 2022 | 3.58 x |
Net Debt 2022 | 6.58B 78.99M | Net Debt 2023 | 7.79B 93.53M | EV / Sales 2023 | 2.63 x |
P/E ratio 2022 |
54.7
x | P/E ratio 2023 |
-61.3
x | Employees | - |
Yield 2022 |
0.28% | Yield 2023 |
-
| Free-Float | 39.28% |
Latest transcript on Shilpa Medicare Ltd
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 87-11-19 | |
Alpesh Dalal
DFI | Director of Finance/CFO | - | 21-05-30 |
Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 87-11-19 | |
Director/Board Member | 58 | 21-09-01 | |
Arvind Vasudeva
BRD | Director/Board Member | 63 | 21-09-01 |
1st Jan change | Capi. | |
---|---|---|
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |